
Aimei Health Technology Co., Ltd (AFJK)
$
52.6
+0.11 (0.21%)
Key metrics
Financial statements
Free cash flow per share
-0.1794
Market cap
322 Million
Price to sales ratio
0
Debt to equity
0.0394
Current ratio
0.0090
Income quality
-0.5100
Average inventory
0
ROE
0.0285
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
The EBITDA is -$1,065,000.00 a key indicator of the company's operational profitability, which provides insight into its ability to generate earnings before interest, taxes, depreciation, and amortization. In assessing profitability, the company recorded a net income of $2,552,000.00 reflecting its overall financial performance. Furthermore, the company incurred an income tax expense of $0.00 indicating its tax obligations and compliance with regulatory requirements. An analysis of operational costs reveals that the company reported selling, general, and administrative expenses of $0.00 which sheds light on its operational overhead costs necessary for running day-to-day activities. The gross profit ratio is 0.00 reflecting the efficiency of the company's production and sales operations, which is crucial for long-term sustainability and growth. On the investment side, the stock is affordable at $11.32 suitable for budget-conscious investors looking for entry points in the market. Despite its affordability, the stock has a low average trading volume of 222,286.00 indicating lower market activity that may affect liquidity. With a market capitalization of $322,003,156.00 the company is classified as a small-cap player, positioning it within a specific growth segment of the market. It is a key player in the Shell Companies industry, contributing significantly to the overall market landscape and influencing trends within its sector. Furthermore, it belongs to the Financial Services sector, driving innovation and growth, which makes it an intriguing option for investors interested in emerging opportunities.
Investing in Aimei Health Technology Co., Ltd (AFJK) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B-, with a Bearish outlook. Always conduct your own research before investing.
Analysts predict Aimei Health Technology Co., Ltd stock to fluctuate between $6.75 (low) and $130.37 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2026-01-30, Aimei Health Technology Co., Ltd's market cap is $322,003,156, based on 6,121,733 outstanding shares.
Compared to Meta Platforms, Inc. Class A Common Stock, Aimei Health Technology Co., Ltd has a Lower Market-Cap, indicating a difference in performance.
To buy Aimei Health Technology Co., Ltd (AFJK) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for AFJK. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Revenue: $0 | EPS: $0.28 | Growth: 1,373.68%.
Visit /investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $130.37 (2025-12-31) | All-time low: $6.75 (2025-12-04).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News

defenseworld.net
a month ago
Aimei Health Technology Co., Ltd. (NASDAQ: AFJK - Get Free Report) gapped up before the market opened on Friday. The stock had previously closed at $64.01, but opened at $85.40. Aimei Health Technology shares last traded at $83.6580, with a volume of 77,152 shares. Wall Street Analyst Weigh In Separately, Weiss Ratings restated a "sell

defenseworld.net
a month ago
Aimei Health Technology Co., Ltd. (NASDAQ: AFJK - Get Free Report) shares hit a new 52-week high during trading on Wednesday. The stock traded as high as $117.48 and last traded at $112.7590, with a volume of 159318 shares. The stock had previously closed at $82.58. Analyst Upgrades and Downgrades Separately, Weiss Ratings restated a

feeds.benzinga.com
2 months ago
Aimei Health shares surged 1,006.25% in Tuesday's regular session before falling 46.89% in after-hours trading.

investorplace.com
2 years ago
Aimei Health Technology (NASDAQ: AFJK ) stock is surprisingly down today despite news that the blank-check company will merge with United Hydrogen Group in a special purpose acquisition company (SPAC) merger worth roughly $1.6 billion. Indeed, United Hydrogen will go public on the Nasdaq through a very fashionable SPAC merger with Aimei, with a new ticker to boot.
See all news